ASPIRINPLUS
Dead / Abandoned — Abandoned — after inter partes decision (as of 18 Dec 2009)
What this means for you
This application is over — abandoned 18 Dec 2009. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78874352
- Mark type
- Stylized text
- Filed
- 02 May 2006
- Published for opposition
- 12 Dec 2006
- Abandoned
- 18 Dec 2009
Goods and services
- Class 005 — Pharmaceuticals: Aspirin in combination with nutritional supplements and synergistic pharmaceutical preparations for the treatment of arthritis, allergies, anemia, anti-aging, antioxidants, antipyretics, antacids, anti-emetics, nausea, antiviral, cancer, cardiovascular disease, circulation conditions, cough from colds, dementia, depression, diabetes, digestion, energy, eye care, high cholesterol, high homocystine levels, hypertension, irritable bowel syndrome, insomnia, inflammation relief, constipation, menopause, neurological conditions, osteoporosis, pain, prostate care, urological symptoms, and vitamin and mineral deficiencies
Owner
- INNERCAP Technologies, Inc., Tampa, FL, US
- INNERCAP Technologies, Inc., Tampa, FL, US
Prosecution history
- 18 Apr 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Dec 2009 — ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
- 18 Dec 2009 — ABANDONMENT - AFTER INTER PARTES DECISION
- 18 Dec 2009 — OPPOSITION TERMINATED NO. 999999
- 18 Dec 2009 — OPPOSITION DISMISSED NO. 999999
- 11 Apr 2007 — OPPOSITION INSTITUTED NO. 999999
- 10 Jan 2007 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 12 Dec 2006 — PUBLISHED FOR OPPOSITION
- 22 Nov 2006 — NOTICE OF PUBLICATION
- 24 Oct 2006 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 20 Oct 2006 — ASSIGNED TO LIE
- 18 Oct 2006 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Oct 2006 — EXAMINER'S AMENDMENT ENTERED
- 17 Oct 2006 — EXAMINERS AMENDMENT E-MAILED
- 17 Oct 2006 — EXAMINERS AMENDMENT -WRITTEN